A Cost-Benefit Analysis to Assess the Effectiveness of Frontal Center Curtain Airbag

被引:1
|
作者
Lee, Bo Kyeong [1 ]
Han, Eun Jin [1 ]
Sohn, So Young [1 ]
Kim, Yong Sun [2 ,3 ]
Yoon, Jong Young [2 ,3 ]
Choi, Jun Yeol [2 ,3 ]
机构
[1] Yonsei Univ, Dept Informat & Ind Engn, 50 Yonsei Ro Seodaemun Gu, Seoul 03722, South Korea
[2] Hyundai Motor Co, Res & Dev Div, Whasung Gun 445706, Kyunggi Do, South Korea
[3] Kia Motors Corp, Whasung Gun 445706, Kyunggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
frontal center curtain airbag; vehicle safety system; Cost-Benefit Analysis; SAFETY BELT USE; DECISION-MAKING; CRASH; ASSOCIATION; PERFORMANCE; FATALITIES; SEVERITY; BAGS;
D O I
10.3390/su9101745
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Several new varieties of airbags are under consideration for development. However, their commercialization decision must be backed by a positive Cost-Benefit Analysis (CBA) outcome. In this study, we propose a CBA framework for the frontal center curtain airbag, a newly designed safety system intended to reduce the injury risk of rear-seat passengers. The proposed CBA covers not only economic benefits of the producer but also the effectiveness in sustainable reduction of the fatal and injury rate. In this context, with accumulated field data on road traffic accidents, a forecasting method reflecting the reduced casualties and the market share of vehicle sales associated with frontal center curtain airbag is utilized. Our results suggest that the use of frontal center curtain airbags helps to reduce the number of casualties with a Maximum Abbreviated Injury Scale (MAIS) of 3 or above by 87.4%. Furthermore, both the initial market penetration rate and price of the frontal center curtain airbag significantly influence its socioeconomic benefits. By evaluating the effectiveness of the frontal center curtain airbag, our study can contribute to the decision making for its commercialization.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain
    Simpson, Kit N.
    Fossler, Michael J.
    Wase, Linda
    Demitrack, Mark A.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (15) : 1107 - 1119
  • [22] COST-EFFECTIVENESS AND COST-BENEFIT IN CHOLERA CONTROL
    ABELSMITH, B
    [J]. WHO CHRONICLE, 1973, 27 (10) : 407 - 409
  • [23] Cost-benefit and cost-effectiveness analysis of drug abuse treatment services
    Cartwright, WS
    [J]. EVALUATION REVIEW, 1998, 22 (05) : 609 - 636
  • [24] APPLICATION OF COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS TO CLINICAL-PRACTICE
    BOOTMAN, JL
    MCGHAN, WF
    SCHONDELMEYER, SW
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (03): : 235 - 243
  • [25] Single-Neuron Mechanisms Underlying Cost-Benefit Analysis in Frontal Cortex
    Hosokawa, Takayuki
    Kennerley, Steven W.
    Sloan, Jennifer
    Wallis, Jonathan D.
    [J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (44): : 17385 - 17397
  • [26] The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It
    Flyvbjerg, Bent
    Bester, Dirk W.
    [J]. JOURNAL OF BENEFIT-COST ANALYSIS, 2021, 12 (03) : 395 - 419
  • [27] Cost-Benefit Analysis in Reasoning
    Alaoui, Larbi
    Penta, Antonio
    [J]. JOURNAL OF POLITICAL ECONOMY, 2022, : 881 - 925
  • [28] Beware the cost-benefit analysis
    Spence, Des
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [29] Incommensurability and cost-benefit analysis
    Adler, M
    [J]. UNIVERSITY OF PENNSYLVANIA LAW REVIEW, 1998, 146 (05) : 1371 - 1418
  • [30] In Defence of Cost-Benefit Analysis
    Ergas, Henry
    [J]. AGENDA-A JOURNAL OF POLICY ANALYSIS AND REFORM, 2009, 16 (03) : 31 - 40